share_log

What the Options Market Tells Us About Bristol-Myers Squibb

What the Options Market Tells Us About Bristol-Myers Squibb

期权市场告诉我们施贵宝的情况
Benzinga ·  16:01

Deep-pocketed investors have adopted a bearish approach towards Bristol-Myers Squibb (NYSE:BMY), and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in BMY usually suggests something big is about to happen.

财力雄厚的投资者对百时美施贵宝(纽约证券交易所代码:BMY)采取了看跌态度,这是市场参与者不容忽视的。我们对本辛加公开期权记录的追踪今天揭示了这一重大举措。这些投资者的身份仍然未知,但是BMY的如此大幅的变动通常表明即将发生重大事件。

We gleaned this information from our observations today when Benzinga's options scanner highlighted 28 extraordinary options activities for Bristol-Myers Squibb. This level of activity is out of the ordinary.

我们今天从观察中收集了这些信息,当时Benzinga的期权扫描仪重点介绍了百时美施贵宝的28项非凡期权活动。这种活动水平与众不同。

The general mood among these heavyweight investors is divided, with 35% leaning bullish and 60% bearish. Among these notable options, 2 are puts, totaling $78,250, and 26 are calls, amounting to $2,153,022.

这些重量级投资者的总体情绪存在分歧,35%的人倾向于看涨,60%的人看跌。在这些值得注意的期权中,有两个是看跌期权,总额为78,250美元,26个是看涨期权,总额为2,153,022美元。

Predicted Price Range

预测的价格区间

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $30.0 to $50.0 for Bristol-Myers Squibb during the past quarter.

分析这些合约的交易量和未平仓合约,看来大型企业一直在关注百时美施贵宝在过去一个季度的价格范围从30.0美元到50.0美元不等。

Analyzing Volume & Open Interest

分析交易量和未平仓合约

Looking at the volume and open interest is an insightful way to conduct due diligence on a stock.

查看交易量和未平仓合约是一种对股票进行尽职调查的有见地的方法。

This data can help you track the liquidity and interest for Bristol-Myers Squibb's options for a given strike price.

这些数据可以帮助您跟踪给定行使价下百时美施贵宝期权的流动性和利息。

Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Bristol-Myers Squibb's whale activity within a strike price range from $30.0 to $50.0 in the last 30 days.

下面,我们可以分别观察百时美施贵宝在过去30天行使价范围内所有鲸鱼活动的看涨和看跌期权交易量和未平仓合约的变化。

Bristol-Myers Squibb Option Activity Analysis: Last 30 Days

百时美施贵宝期权活动分析:过去 30 天

1721332876_0.png

Noteworthy Options Activity:

值得注意的期权活动:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
BMY CALL TRADE BULLISH 06/20/25 $7.15 $6.85 $7.1 $40.00 $852.0K 747 42
BMY CALL SWEEP BEARISH 08/16/24 $1.45 $1.42 $1.43 $44.00 $248.8K 2.8K 774
BMY CALL SWEEP BEARISH 08/02/24 $2.98 $2.9 $2.9 $41.00 $116.0K 515 34
BMY CALL SWEEP BULLISH 08/16/24 $1.42 $1.39 $1.42 $44.00 $108.2K 2.8K 12
BMY CALL TRADE BULLISH 07/26/24 $0.45 $0.42 $0.45 $46.00 $67.5K 510 207
符号 看跌/看涨 交易类型 情绪 Exp。日期 出价 价格 行使价 总交易价格 未平仓合约 音量
BMY 打电话 贸易 看涨 06/20/25 7.15 美元 6.85 美元 7.1 美元 40.00 美元 852.0 万美元 747 42
BMY 打电话 粗鲁的 08/16/24 1.45 美元 1.42 1.43 美元 44.00 美元 248.8 万美元 2.8K 774
BMY 打电话 粗鲁的 08/02/24 2.98 美元 2.9 美元 2.9 美元 41.00 美元 116.0 万美元 515 34
BMY 打电话 看涨 08/16/24 1.42 1.39 美元 1.42 44.00 美元 108.2 万美元 2.8K 12
BMY 打电话 贸易 看涨 07/26/24 0.45 美元 0.42 美元 0.45 美元 46.00 美元 67.5 万美元 510 207

About Bristol-Myers Squibb

关于百时美施贵宝

Bristol-Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the U.S., showing a higher dependence on the U.S. market than most of its peer group.

百时美施贵宝发现、开发和销售用于心血管、癌症和免疫疾病等各种治疗领域的药物。布里斯托尔的重点是免疫肿瘤学,该公司是该领域的药物开发领导者。布里斯托尔将近70%的总销售额来自美国,这表明其对美国市场的依赖程度高于大多数同行。

Having examined the options trading patterns of Bristol-Myers Squibb, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance

在研究了百时美施贵宝的期权交易模式之后,我们的注意力现在直接转向了该公司。这种转变使我们能够深入研究其目前的市场地位和表现

Current Position of Bristol-Myers Squibb

百时美施贵宝的现状

  • Currently trading with a volume of 14,236,612, the BMY's price is down by -1.58%, now at $42.47.
  • RSI readings suggest the stock is currently may be approaching overbought.
  • Anticipated earnings release is in 8 days.
  • BMY目前的交易量为14,236,612美元,价格下跌了-1.58%,目前为42.47美元。
  • RSI读数表明,该股目前可能接近超买。
  • 预计财报将在8天后发布。

What The Experts Say On Bristol-Myers Squibb

专家对百时美施贵宝的看法

In the last month, 1 experts released ratings on this stock with an average target price of $41.0.

上个月,1位专家发布了该股的评级,平均目标价为41.0美元。

  • Maintaining their stance, an analyst from Barclays continues to hold a Equal-Weight rating for Bristol-Myers Squibb, targeting a price of $41.
  • 巴克莱银行的一位分析师坚持其立场,继续对百时美施贵宝持有同等权重评级,目标价格为41美元。

Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Bristol-Myers Squibb options trades with real-time alerts from Benzinga Pro.

期权交易带来更高的风险和潜在的回报。精明的交易者通过不断自我教育、调整策略、监控多个指标以及密切关注市场走势来管理这些风险。通过 Benzinga Pro 的实时提醒,随时了解百时美施贵宝期权的最新交易。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发